Condition
Mesothelioma|Pleural Mesothelioma
Estimated Enrollment: 6
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 05-0815-C
Study First Received: May 6, 2009
Last Updated: July 29, 2016
Estimated Primary Completion Date: October 2012
Primary Outcome Measures:
median relapse-free survival (RFS)
Sponsors and Collaborators:
University Health Network, Toronto|Eli Lilly and Company
Website Link: https://ClinicalTrials.gov/show/NCT00895648
